WFRF:(Floege Juergen)
Search: WFRF:(Floege Juergen) > (2023) > Prophylactic and ea...
- 1 of 1
- Previous record
- Next record
- To hitlist
Prophylactic and early outpatient treatment of COVID-19 in patients with kidney disease: considerations from the Immunonephrology Working Group of the European Renal Association (ERA-IWG)
-
- Hilhorst, Marc (author)
- Univ Amsterdam, Netherlands
-
- Bemelman, Frederike J. (author)
- Univ Amsterdam, Netherlands
-
- Bruchfeld, Annette (author)
- Karolinska Institutet,Linköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Region Östergötland, Njurmedicinska kliniken US,Karolinska Univ Hosp, Sweden; CLINTEC Karolinska Inst, Sweden
- show more...
- show less...
- (creator_code:org_t)
- 2023-03-06
- 2023
- English.
- In: Nephrology, Dialysis and Transplantation. - : OXFORD UNIV PRESS. - 0931-0509 .- 1460-2385. ; 38:8, s. 1807-1816
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic led to rapid vaccine development and large global vaccination schemes. However, patients with immune-mediated kidney disease, chronic kidney diseases and kidney transplant recipients show high non-response rates to vaccination despite more than three vaccinations and, consequently, reduced viral clearance capacity when infected while receiving certain immunosuppressants, carrying an elevated risk for coronavirus disease 2019 (COVID-19)-related morbidity and mortality. SARS-CoV-2 evolution has been characterized by the emergence of novel variants and spike mutations contributing to waning efficacy of neutralizing antibodies. To this end, the therapeutic field expands from vaccination towards a combined approach of immunization, pre-exposure prophylaxis and early post-exposure treatment using direct-acting antivirals and neutralizing monoclonal antibodies to treat early in the disease course and avoid hospitalization. This expert opinion paper from the Immunonephrology Working Group of the European Renal Association (ERA-IWG) summarizes available prophylactic and/or early treatment options (i.e. neutralizing monoclonal antibodies and direct-acting antivirals) of SARS-CoV-2-infected patients with immune-mediated kidney disease, chronic kidney disease and kidney transplant recipients.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Urology and Nephrology (hsv//eng)
Keyword
- antiviral therapy; COVID-19; kidney; prophylaxis; transplantation
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Nephrology, Dialysis and Transplantation (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Hilhorst, Marc
- Bemelman, Freder ...
- Bruchfeld, Annet ...
- Fernandez-Juarez ...
- Floege, Juergen
- Frangou, Eleni
- show more...
- Goumenos, Dimitr ...
- van Kooten, Cees
- Kronbichler, And ...
- Stevens, Kate I
- Turkmen, Kultigi ...
- Wiersinga, W. Jo ...
- Anders, Hans-Joa ...
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Urology and Neph ...
- Articles in the publication
- Nephrology, Dial ...
- By the university
- Linköping University
- Karolinska Institutet
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
